Clinical Research Directory
Browse clinical research sites, groups, and studies.
Residual IDH1-Mutant Tumor Cell Quantification Study
Sponsor: NYU Langone Health
Summary
This is a single-site, single-arm, prospective, interventional cohort study using intraoperative ultra-rapid droplet digital polymerase chain reaction (UR- ddPCR) to assess residual IDH1-mutant tumor at the end of surgical resection and, if positive, guide additional resection in real-time.
Official title: Intraoperative Quantification of Residual IDH1-mutant Tumor Cells Via Ultra-Rapid Droplet Digital PCR
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
105
Start Date
2025-12
Completion Date
2030-12
Last Updated
2025-10-21
Healthy Volunteers
No
Conditions
Interventions
UR-ddPCR
The investigational UR-ddPCR assay will be performed on collected tissue specimens during the participant's scheduled surgical visit.
Locations (1)
NYU Langone Health
New York, New York, United States